Keys to harnessing the value of digital biomarkers in clinical trials
- By Lilian Zhang and Nikhil Bhojwani
- Biopharma ,
- Medtech ,
- Digital ,
Digital biomarkers are no longer just a pipe dream—they are here, and their use is potentially at an inflection point. However, successful implementation requires more than enthusiasm; it demands thoughtful strategies tailored to each clinical innovation, therapeutic area, and digital tool.